Carlos Martinez

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Direct Oral Anticoagulants

Top Venues

Thrombosis and haemostasis

American journal of hematology

Heart (British Cardiac Society)

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander T Cohen, Christopher Wallenhorst, Marcella Rivera, Cihan Ay, Bernhard Schaefer, Khaled Abdelgawwad, George Psaroudakis, Gunnar Brobert, Anders Ekbom, Agnes Y Y Lee, Alok A Khorana, Cecilia Becattini, Marc Carrier, Craig I Coleman, Carlos Martinez
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study. Thrombosis and haemostasis (2024)
Alexander Cohen, Christopher Wallenhorst, Marcela Rivera, Cihan Ay, Bernhard Schaefer, Khaled Abdelgawwad, George Psaroudakis, Gunnar Brobert, Anders Ekbom, Agnes Y Y Lee, Alok A Khorana, Cecilia Becattini, Marc Carrier, Craig I Coleman, Carlos Martinez
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low Molecular Weight Heparin - The OSCAR-UK Study. Thrombosis and haemostasis (2024)
Alexander T Cohen, Christopher Wallenhorst, Satarupa Choudhuri, Ayman Nassar, Kevin G Pollock, Carlos Martinez
A novel risk prediction score for clinically significant bleeding in patients anticoagulated for venous thromboembolism with active cancer. Thrombosis and haemostasis (2023)
Christopher Wallenhorst, Carlos Martinez, Ben Freedman
Risk of Ischemic Stroke in Asymptomatic Atrial Fibrillation Incidentally Detected in Primary Care Compared with Other Clinical Presentations. Thrombosis and haemostasis (2021)
Renate B Schnabel, Christopher Wallenhorst, Daniel Engler, Stefan Blankenberg, Norbert Pfeiffer, Ngoc Anh Spruenker, Matthias Buettner, Matthias Michal, Karl J Lackner, Thomas Münzel, Philipp S Wild, Carlos Martinez, Ben Freedman, null null
Refined atrial fibrillation screening and cost-effectiveness in the German population. Heart (British Cardiac Society) (2021)
Carlos Martinez, Anja Katholing, Christopher Wallenhorst, Alexander T Cohen
Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients. British journal of haematology 189 (3) (2020)
Christopher Wallenhorst, Ami Patel, Amgad Shebl, Alphonse Hubsch, Toby L Simon, Carlos Martinez
Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study. Transfusion 60 (7) (2020)
Carlos Martinez, Anja Katholing, Kerstin Folkerts, Stephan Rietbrock
Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study. Current medical research and opinion 34 (11) (2018)
Carlos Martinez, Douglas J Watson, Amgad Shebl, Christopher Wallenhorst, Alphonse Hubsch, Toby L Simon
Impact of screening and exclusion of high anti-A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital-based cohort study in the US. American journal of hematology 93 (1) (2017)